| Literature DB >> 28137906 |
Amrit Kirpalani1, Michael J Rieder1, Kevin C Bax1, Guido Filler1.
Abstract
An infant boy with steroid-resistant nephrotic syndrome (idiopathic membranous glomerulonephropathy) achieved remission with ciclosporin but developed eosinophilia and high IgE levels (max 19 000 iU/mL). Conversion to tacrolimus resulted in chronic diarrhoea (eosinophilic gastroenteritis), muscle weakness, polyserositis and failure-to-thrive. In contrast, a trial without tacrolimus resulted in a ciclosporin-responsive relapse, therapy-resistant focal seizures with generalised spikes, worsening muscle weakness and diarrhoea. The patient was weaned off of ciclosporin and completely normalised. In vitro testing demonstrated decreased viability of the patient's cells when incubated with calcineurin inhibitors (ciclosporin, 70%; tacrolimus, 80% compared to control cells), supporting their role in this adverse drug reaction. 2017 BMJ Publishing Group Ltd.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28137906 PMCID: PMC5293966 DOI: 10.1136/bcr-2016-218496
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X